SCHEMBL13487137

SCHEMBL13487137

CC1(C)c2ccccc2-c2c(-c3c4ccccc4c(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c4ccc(-c5ccccc5)cc34)cccc21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.32
MEN1 O00255 4/20 0.31
KMT2A Q03164 4/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPT P10636 3/20 0.31
HPGD P15428 3/20 0.31
KDM4E B2RXH2 2/20 0.31
ATM Q13315 2/20 0.31
TP53 P04637 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
MAPK1 P28482 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
PDK2 Q15119 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487393 0.94 PDK2 (0.33) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13487311 0.93 KDM4E (0.34) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13487205 0.92 KDM4E (0.36) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13487135 0.90 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL13487068 0.90 MEN1 (0.38) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13487109 0.88 PIK3CA (0.32) PDK2
SCHEMBL17152008 0.88 L3MBTL1 (0.35) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13487122 0.87 ESR1 (0.36) ALDH1A1MAPTSMN1; SMN2LMNAPDK2
SCHEMBL13487111 0.86 CYP17A1 (0.31) PDK2
SCHEMBL13487548 0.86 MEN1 (0.34) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 L3MBTL1 1193/4885MEN1 3017/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.